COVID-19 – Apiphytotherapeutic opportunities for prevention and treatment

COVID-19 – Apiphytotherapeutic opportunities for prevention and treatment

In December 2019, the COVID-19 epidemic broke out in Wuhan (China), which soon spread worldwide, generating a pandemic that put the medical world in difficulty. In the absence of an etiological treatment and an effective vaccine, the researchers also turned their attention to alternative treatments,...

Full description

Bibliographic Details
Main Author:	Cristina MUNTEANU
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2020-12-01
Series:	Romanian Journal of Medical Practice
Subjects:	sars-cov-2 covid-19 molecular docking alternative medicine phytotherapy phytocompounds quercetin flavonoids propolis mushrooms micronutrients
Online Access:	https://rjmp.com.ro/articles/2020.4/RJMP_2020_4_Art-02.pdf

Similar Items

Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)
by: Ruben Manuel Luciano Colunga Biancatelli, et al.
Published: (2020-06-01)

The Potential Anticancer Activity of Phytoconstituents Against Gastric Cancer—A Review on In Vitro, In Vivo, and Clinical Studies
by: Sylwia Nakonieczna, et al.
Published: (2020-11-01)

Health-enhancing activity of ellagic acid and ellagitannin of selected species from the genus Rubus – Review
by: MIKOŁAJ KOSTRYCO, et al.
Published: (2018-07-01)

Molecular interaction analysis of Sulawesi propolis compounds with SARS-CoV-2 main protease as preliminary study for COVID-19 drug discovery
by: Muhamad Sahlan, et al.
Published: (2021-01-01)

Quercetin with lycopene modulates enzymic antioxidant genes pathway in isoproterenol cardiotoxicity in rats: Cardioprotection by quercetin & lycopene
by: LIJUAN Chen, et al.
Published: (2021-01-01)

The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)

Acetogenins from Annona muricata as potential inhibitors of antiapoptotic proteins: a molecular modeling study
by: Antony P, et al.
Published: (2016-04-01)

Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
by: Ramesh K. Goyal, Jaseela Majeed, Rajiv Tonk, Mahaveer Dhobi, Bhoomika Patel, Kalicharan Sharma, Subbu Apparsundaram
Published: (2020-09-01)

Inhibitory potency of ursolic acid derivatives on osteoporosis target tryptophan hydroxylase 1 (Tph1)
by: Kiran Kumar Vokkerla, et al.
Published: (2019-07-01)

Kerja Harmoni Zat Gizi dalam Meningkatkan Imunitas Tubuh Terhadap Covid-19: Mini Review
by: Sri Sumarmi
Published: (2020-09-01)

Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: A probable prelude to control some variants of coronavirus including Delta
by: Suliman Khan, et al.
Published: (2021-10-01)

Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic
by: Mohammad Amin Khazeei Tabari, et al.
Published: (2020-01-01)

Molecular docking study of active phytocompounds from the methanolic leaf extract of vitex negundo against cyclooxygenase-2
by: Deepa Murugesan, et al.
Published: (2014-03-01)

Prospects of nutritional interventions in the care of COVID-19 patients
by: Sabiha Alam, et al.
Published: (2021-02-01)

Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study
by: Apriliana Cahya Khayrani, et al.
Published: (2021-03-01)

Medicinal plant-based saponins targeting COVID-19 Mpro in silico
by: Mohd Rehan, et al.
Published: (2021-05-01)

Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19
by: Sucheta Khubber, et al.
Published: (2020-11-01)

Antimalarial phytochemicals as inhibitors against COVID-19 ACE2 receptor: Computational screening
by: Ouided BENSLAMA, et al.
Published: (2021-04-01)

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment
by: Xiaoqiang Huang, et al.
Published: (2021-06-01)

COVID-19 coronavirus: pathogenesis, clinical features, diagnostics, epidemiology, prevention and control
by: Yousra El-Maradny, et al.
Published: (2020-06-01)

Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework
by: Sebastià Galmés, et al.
Published: (2020-09-01)

Medicinal Plants Effective in the Prevention and Control of Coronaviruses
by: Saghar Ketabchi, et al.
Published: (2021-01-01)

Can Non-steroidal Anti-inflammatory Drugs Affect the Interaction Between Receptor Binding Domain of SARS-COV-2 Spike and the Human ACE2 Receptor? A Computational Biophysical Study
by: Lenin A. González-Paz, et al.
Published: (2020-11-01)

Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave
by: Teresa-Maria Tomasa-Irriguible, et al.
Published: (2021-08-01)

Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review
by: Samad N, et al.
Published: (2021-05-01)

Potential of Flavonoid-Inspired Phytomedicines against COVID-19
by: Wilfred Ngwa, et al.
Published: (2020-06-01)

Prediction of Asiatic Acid Derivatives Affinity Against SARS-CoV-2 Main Protease Using Molecular Docking
by: Ida Musfiroh, et al.
Published: (2020-07-01)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
by: Panthakarn Rangsinth, et al.
Published: (2021-03-01)

Anti-inflammatory potential of Quercetin in COVID-19 treatment
by: Ali Saeedi-Boroujeni, et al.
Published: (2021-01-01)

Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies
by: Giacomo Di Matteo, et al.
Published: (2020-08-01)

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis
by: Deep Bhowmik, et al.
Published: (2021-03-01)

Thermodynamic, kinetic and docking studies of some unsaturated fatty acids-quercetin derivatives as inhibitors of mushroom tyrosinase
by: Morteza Vaezi, et al.
Published: (2020-12-01)

Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
by: Razie Sabet, et al.
Published: (2021-06-01)

Plant Occurring Flavonoids as Modulators of the Aryl Hydrocarbon Receptor
by: Elizabeth Goya-Jorge, et al.
Published: (2021-04-01)

Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease
by: Andresa Aparecida Berretta, et al.
Published: (2020-11-01)

Physiological and clinical aspects in COVID-19
by: R. Kodidala Satyanath, et al.
Published: (2020-12-01)

Perspective on the Primary Prevention of COVID-19
by: Franshesca L. Sedano-Chiroque, et al.
Published: (2020-07-01)

Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors Than Isoflavone and Flavones
by: Bozza, P.T, et al.
Published: (2022)

The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions
by: Mohammad Hossain Shariare, et al.
Published: (2021-02-01)

The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
by: Rodrigo M Burgos, et al.
Published: (2021-02-01)